Skip to main content

Klingenstein Fields & Co LP

SEC CIK
0000859872
Latest filing
Aug 5, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Klingenstein Fields & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
99,718
Value
$9.05M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABT by Klingenstein Fields & Co LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202699,718$9.05M0.3%−10,584−9.6%ReducedHolders
Q1 2026110,302$11.3M0.4%−1,113−1.0%ReducedHolders
Q4 2025111,415$14.0M0.5%−824−0.7%ReducedHolders
Q3 2025112,239$15.0M0.6%−3,481−3.0%ReducedHolders
Q2 2025115,720$15.7M0.6%−14,537−11.2%ReducedHolders
Q1 2025130,257$17.3M0.7%+155+0.1%AddedHolders
Q4 2024130,102$14.7M0.6%+2,701+2.1%AddedHolders
Q3 2024127,401$14.5M0.6%+171+0.1%AddedHolders
Q2 2024127,230$13.2M0.5%+134+0.1%AddedHolders
Q1 2024127,096$14.4M0.6%−2,159−1.7%ReducedHolders
Q4 2023129,255$14.2M0.6%−2,415−1.8%ReducedHolders
Q3 2023131,670$12.8M0.6%−162−0.1%ReducedHolders
Q2 2023131,832$14.4M0.7%−2,080−1.6%ReducedHolders
Q1 2023133,912$13.6M0.7%+1,357+1.0%AddedHolders
Q4 2022132,555$14.6M0.8%+156+0.1%AddedHolders
Q3 2022132,399$12.8M0.7%+1,703+1.3%AddedHolders
Q2 2022130,696$14.2M0.7%−1,053−0.8%ReducedHolders
Q1 2022131,749$15.6M0.7%+338+0.3%AddedHolders
Q4 2021131,411$18.5M0.7%−1,590−1.2%ReducedHolders
Q3 2021133,001$15.7M0.7%−2,971−2.2%ReducedHolders
Q2 2021135,972$15.8M0.7%−3,982−2.8%ReducedHolders
Q1 2021139,954$16.8M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.